On Friday, Shares of United States Steel Corp. (NYSE:X), gained 4.68% to $25.03.
United States Steel Corporation, declared that its Board of Directors declared a dividend of five cents per share on U. S. Steel Common Stock. The dividend is payable June 10, 2015, to stockholders of record at the close of business May 13, 2015.
United States Steel Corporation produces and sells flat-rolled and tubular steel products in North America and Europe. It operates through three segments: Flat-Rolled Products (Flat-Rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular).
At the end of Friday’s trade, Shares of ConocoPhillips (NYSE:COP), lost -0.72% to $65.11.
Deutsche Bank reiterated their buy rating on shares of ConocoPhillips, in a research note released on Saturday morning.
ConocoPhillips (COP) last issued its quarterly earnings data on Thursday, April 30th. The company stated ($0.18) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.19) by $0.01. During the same quarter in the preceding year, the company posted $1.81 earnings per share. On average, analysts predict that ConocoPhillips will post $0.36 earnings per share for the current fiscal year.
ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids worldwide. Its portfolio comprises shale and oil sands assets; lower-risk legacy assets in North America, Europe, Asia, and Australia; various international developments; and exploration prospects. ConocoPhillips was founded in 1917 and is headquartered in Houston, Texas.
Finally, Bruker Corporation (NASDAQ:BRKR), ended its last trade with 2.94% gain, and closed at $19.60.
Bruker Corporation, declared that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO) of Bruker since July 2012, presented his resignation, effective June 12, 2015, in order to pursue other interests. Mr. Wagner has informed the Company that he has accepted a position as Chief Financial Officer of Ortho-Clinical Diagnostics, Inc., and will commence service in that position in late June 2015. Mr. Wagner’s resignation is not the result of any dispute or disagreement with the Company or any matter regarding the Company’s accounting practices or financial statements.
Mr. Wagner is predictable to continue in his role as Bruker’s Chief Financial Officer until his departure from the Company, and he will work during the next few weeks to ensure an orderly transition of his responsibilities. Bruker intends to initiate a search and until such time as a new CFO is designated, Mr. Anthony L. Mattacchione, an executive officer and the Company’s Senior Vice President of Finance & Accounting, will serve as interim CFO, effective upon Mr. Wagner’s departure. Mr. Mattacchione joined the Company in February 2013, and is presently responsible for the Company’s global finance and accounting functions, counting corporate accounting, financial planning & analysis, treasury, tax, shared financial services, internal controls and internal audit. Preceding to joining the Company, Mr. Mattacchione served as Chief Financial Officer of EMD Millipore Corporation, a partner of Merck KGaA, and as Vice President, Controller and Chief Accounting Officer of Millipore Corporation.
Bruker Corporation, together with its auxiliaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
